← SR1 Capital Management
What podcasts say about SR1 Capital Management
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about SR1 Capital Management
3 statements · 3 positive
SR1 generated strong financial returns during its GSK corporate-venture period.
“The fund did incredibly well from a financial return standpoint.”
Open the episode · AI, China, And Biotech Investing With SR One's Simeon George, M.D.Listen at 6:18
SR1 manages more than $2 billion across multiple funds.
“we now manage over 2 billion across multiple funds”
Open the episode · AI, China, And Biotech Investing With SR One's Simeon George, M.D.Listen at 9:03
SR1 invests in platforms only when focused on medicines addressing specific unmet needs.
“the platform has to be focused around a medicine in a particular unmet need that we believe is going to create significant value if we can hit that target product profile”
Open the episode · AI, China, And Biotech Investing With SR One's Simeon George, M.D.Listen at 14:16
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.